Syngenta seeks $20bn loan: but is it ChemChina risk?

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Syngenta seeks $20bn loan: but is it ChemChina risk?

Syngenta ChemChina PA 230x150

The unusual financing structure that China National Chemical Corp (ChemChina) is using for its $43bn acquisition of Syngenta drew a varied response from banks in Europe this week. Some saw the non-recourse structure for $20bn of the debt as shielding lenders from exposure to ChemChina, while others did not.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article